Literature DB >> 16884013

Seroprevalence of Toxoplasma gondii in pregnant women and cats in Grenada, West Indies.

Sumita P Asthana1, Calum N L Macpherson, Stanley H Weiss, Richard Stephens, Thomas N Denny, R N Sharma, J P Dubey.   

Abstract

Prevalence of antibodies against Toxoplasma gondii was studied in 534 pregnant women and 40 domestic cats in Grenada, West Indies. Antibodies (IgG) for T. gondii were sought in human sera by an enzyme-linked immunosorbent assay and in cat sera by using the modified agglutination test (MAT). Antibodies were found in 57 % of pregnant women. Seroprevalence increased with age; 51% of 15- to 19-yr-old women (100 total) had antibodies versus 60% of 20- to 24-yr-old women (127 total). Antibodies to T. gondii (MAT, 1:25 serum dilution) were found in 35% of cats; titers were 1:25 in 7 cats, 1:50 in 4 cats, and 1:500 in 3 cats. Epidemiological data suggested that the ingestion of food or water contaminated with oocysts was an important mode of transmission of T. gondii to women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884013     DOI: 10.1645/GE-762R.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  10 in total

1.  Toxoplasmosis-serological evidence and associated risk factors among pregnant women in southern Thailand.

Authors:  Veeranoot Nissapatorn; Chitkasaem Suwanrath; Nongyao Sawangjaroen; Lau Yee Ling; Verapol Chandeying
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

2.  Seroprevalence of Toxoplasma gondii antibodies of stray cats in Garmsar, Iran.

Authors:  Maysam Tehrani-Sharif; Sina Jahan; Seyed Mohsen Alavi; Mohsen Khodami
Journal:  J Parasit Dis       Date:  2013-09-03

3.  Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in south western, Saudi Arabia.

Authors:  Mona A Almushait; Saad M Bin Dajem; Nahla M Elsherbiny; Mamdoh A Eskandar; Tarik A Al Azraqi; Laila M Makhlouf
Journal:  J Parasit Dis       Date:  2012-11-02

Review 4.  The impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: an overview and update.

Authors:  Panagiotis Karanis; Hebatalla M Aldeyarbi; Marzieh E Mirhashemi; Khalil M Khalil
Journal:  Environ Sci Pollut Res Int       Date:  2012-09-19       Impact factor: 4.223

Review 5.  Molecules to modeling: Toxoplasma gondii oocysts at the human-animal-environment interface.

Authors:  Elizabeth VanWormer; Heather Fritz; Karen Shapiro; Jonna A K Mazet; Patricia A Conrad
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2012-12-04       Impact factor: 2.268

Review 6.  Toxoplasmosis in the Caribbean islands: literature review, seroprevalence in pregnant women in ten countries, isolation of viable Toxoplasma gondii from dogs from St. Kitts, West Indies with report of new T. gondii genetic types.

Authors:  Jitender P Dubey; Shiv Kumar Verma; Isabelle Villena; Dominique Aubert; Régine Geers; Chunlei Su; Elise Lee; Martin S Forde; Rosina C Krecek
Journal:  Parasitol Res       Date:  2016-01-14       Impact factor: 2.289

7.  Foll Detection of Toxoplasma gondii in sheep and goats blood samples by PCR-RFLP in Urmia.

Authors:  Mousa Tavassoli; Mohammad Ghorbanzadehghan; Bijan Esmaeilnejad
Journal:  Vet Res Forum       Date:  2013       Impact factor: 1.054

8.  An analytical study on the awareness and practice relating toxoplasmosis among pregnant women in Casablanca, Morocco.

Authors:  S Ait Hamou; M Laboudi
Journal:  BMC Public Health       Date:  2021-03-16       Impact factor: 3.295

9.  Toxoplasma gondii clonal type III is the dominant genotype identified in Grenadian pigs.

Authors:  Alfred Chikweto; Andy Alhassan; Chunlei Su; Calum Macpherson; Muhammad Iqbal Bhaiyat; Jitender P Dubey
Journal:  Vet Med Sci       Date:  2022-07-09

10.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.